Q Global Advisors’s GeneDx Holdings Warrant WGSWW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-111,701
| Closed | – | – | 50 |
|
|
2026
Q2 | $0 | Hold |
111,701
| – | – | ﹤0.01% | 51 |
|
|
2026
Q1 | $1K | Hold |
111,701
| – | – | ﹤0.01% | 48 |
|
|
2025
Q4 | $5K | Hold |
111,701
| – | – | ﹤0.01% | 40 |
|
|
2025
Q3 | $12K | Hold |
111,701
| – | – | 0.02% | 25 |
|
|
2025
Q2 | $8K | Hold |
111,701
| – | – | 0.01% | 36 |
|
|
2025
Q1 | $23K | Hold |
111,701
| – | – | 0.02% | 27 |
|
|
2024
Q4 | $18K | Sell |
111,701
-3,773
| -3% | -$649 | 0.02% | 28 |
|
|
2024
Q3 | $9K | Hold |
115,474
| – | – | 0.01% | 29 |
|
|
2024
Q2 | $3K | Hold |
115,474
| – | – | ﹤0.01% | 74 |
|
|
2024
Q1 | $6K | Hold |
115,474
| – | – | ﹤0.01% | 81 |
|
|
2023
Q4 | $1K | Hold |
115,474
| – | – | ﹤0.01% | 110 |
|
|
2023
Q3 | $3K | Hold |
115,474
| – | – | ﹤0.01% | 127 |
|
|
2023
Q2 | $1K | Hold |
115,474
| – | – | ﹤0.01% | 158 |
|
|
2023
Q1 | $2K | Hold |
115,474
| – | – | ﹤0.01% | 176 |
|
|
2022
Q4 | $2K | Hold |
115,474
| – | – | ﹤0.01% | 175 |
|
|
2022
Q3 | $17K | Buy |
+115,474
| New | +$32.4K | 0.01% | 39 |
|
Q Global Advisors's WGSWW Position: Q3 2026 in Review
Q Global Advisors sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2026, closing a stake of 111,701 shares.
Q Global Advisors first reported a position in WGSWW in Q3 2022 and held it in 16 quarters. The position peaked at $23K in Q1 2025. 0 funds tracked by Wall St. Rank hold WGSWW as of Q3 2026.
- Q Global Advisors reported no remaining GeneDx Holdings Warrant position as of Q3 2026 after selling out during the quarter.
- Q Global Advisors sold 111,701 GeneDx Holdings Warrant shares in Q3 2026.
- Q Global Advisors first reported a position in GeneDx Holdings Warrant in Q3 2022 and held it in 16 quarters.
- Q Global Advisors's GeneDx Holdings Warrant position peaked at $23K in Q1 2025.
- 0 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2026.
Based on Q Global Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.